Santiago Madero MD, MS, PhD

Dr. Santiago Madero is currently supporting the development and future implementation of clinical trials for research with psychedelic substances for the treatment of depression. He has clinical experience in the use of esketamine and ketamine for the treatment of treatment-resistant depressive disorders. He currently coordinates the working group on psychedelics of the Catalan Society of Psychiatry and Mental Health.